Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Real-world effectiveness and treatment costs of ceftazidime-avibactam versus colistin-meropenem for ICU-acquired MDR gram-negative infections in liver transplant recipients.

BACKGROUND Multidrug-resistant (MDR) Gram-negative infections remain a threat after liver transplantation, yet comparative treatment data in critically ill recipients are scarce. Therapeutic decisions are complicated by immunosuppression, resistance mechanisms, and antimicrobial toxicity. We evaluated ceftazidime-aviba...

A. Kose, Nisa Candas, Ş. Yaşar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.